Press "Enter" to skip to content

Average Broker Rating Watch for Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Sell-side analysts often undertake stock analysis to give their opinions of whether they believe that shares should be bought, sold, or held. Using ratings provided by analysts to Zacks Research, we can see that the current average broker rating on shares of …Read more





Free Stock Performance Review on ViewRay and Three Additional Medical Equipment Stocks

Pre-market today WallStEquitiescom presents the following Medical Appliances and Equipment stocks for review ViewRay Inc NASDAQ VRAY Wright Medical Group NV NASDAQ WMGI Zimmer Biomet Holdings Inc NYSE ZBH a Buy rating on the
Read more

Top Analyst Upgrades and Downgrades Aflac Akamai BioMarin Caesars Entertainment CBS Crocs GW Pharma Medtronic Netflix Sirius XM and More

Synthorx Inc NASDAQ THOR was started with a Buy rating and assigned a 21 price target at RBC Capital Markets Zimmer Biomet Holdings Inc NYSE ZBH was raised to Buy from Neutral and the target price was raised to 127 from 122 versus
Read more

Argus Drops Bullish Zimmer Biomet Thesis On Manufacturing Supply Sales Worries

A sell-side analyst cited product supply and manufacturing issues as well as sales declines in a Friday downgrade of medical device maker Zimmer Biomet Holdings Inc NYSE ZBH Zimmer has faced supply constraints for months having previously estimated
Read more

Zimmer Biomet Holdings Breaks Above 200-Day Moving Average – Bullish for ZBH

In trading on Wednesday shares of Zimmer Biomet Holdings Inc Symbol ZBH crossed above their 200 day moving average of 11819 changing hands as high as 11945 per share Zimmer Biomet Holdings Inc shares are currently trading up about 17 on the day
Read more

Trade of the Day Breakout Targets a Double-Digit Run in ZBH Stock

Zimmer Biomet Holdings Inc NYSEZBH Shares of ZBH stock broke out late last month UBS raised its price objective from 117 to 132 but maintained its Hold rating on shares SP Capital IQ Equity Research which has a Buy rating
Read more

Top Analyst Upgrades and Downgrades Bed Bath Beyond BlackBerry ConocoPhillips JPMorgan Micron PGE Wells Fargo and More

Wedbush Securities maintained its Neutral rating and lowered its price target to 23 was raised to Buy from Neutral with a 75 price target at Buckingham Research Zimmer Biomet Holdings Inc NYSE ZBH was reiterated as Buy with a 140 price target
Read more

Please follow and like us:

Comments are closed.